Caliper Rings NASDAQ Opening Bell, Interview with Kevin Hrusovsky, CEO
"Click Here to view press release & video"Caliper Holds Court for Scientists & Investors - COG2011 Recap!
Click Here!
Latest News
Nov 7, 2011
PerkinElmer Completes Acquisition of Caliper Life SciencesNov 7, 2011
Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing MedicineNov 3, 2011
Caliper Life Sciences Reports Third Quarter 2011 Results More NewsEvents
January 24-26, 2012
SPIE Photonics West 2012February 6-7, 2012
SLAS2012February 15-18, 2012
AGBTMarch 12-14, 2012
ToxExpo More EventsIn Vitro & In Vivo Outsourcing
Caliper provides a wide-range of in vitro & in vivo contract research services through our Discovery Alliances & Services (CDAS) business unit. We offer outsourcing solutions in many areas including Molecular Screening & Profiling, Functional Pharmacology, Drug Safety Assessment, ADME-Tox, PK/PD and In vivo Drug Efficacy Studies.
Learn More About our Screening Assays & Programs through CDAS
Support
We put our Customers First allowing them to focus on their number one priority.Better science...today.
Learn More About Our Support
This month's highlight - Support for preclinical imaging technology grants. Click here to learn more!